ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment
The joint studies showed some improvement in a few biological measures of the disease, but most of the changes were small and not enough to make a difference in delaying cognitive decline.
Announcement as on 04 December 2025

Novo Nordisk gears up for December Ozempic launch in India, sources say
Danish drugmaker Novo Nordisk is set to launch its popular diabetes drug Ozempic in India this month. This move aims to capture a significant share of India's growing weight-loss treatment market. Ozempic, known for its effectiveness in managing type 2 dia
Announcement as on 04 December 2025

India weight-loss market reset? In setback for Novo Nordisk, Dr Reddy's Lab allowed to make semaglutide
The order follows the court’s view that Novo Nordisk’s patent appears prima facie invalid -- a finding that could reshape competitive dynamics in a market valued at around Rs 850 crore.
Announcement as on 03 December 2025

Novo Nordisk India partners with Healthify to launch AI-enabled patient support programme
Novo Nordisk India and Healthify have launched a new programme. It offers AI-assisted lifestyle guidance for people with obesity. This partnership aims to improve patient experience and treatment results. An AI assistant will help users track nutrition thr
Announcement as on 03 December 2025

Generic drug companies rework pricing to gain weight in India’s GLP-1 market as Novo Nordisk slashes Wegovy prices
Indian drugmakers are adjusting prices for weight-loss injections after Novo Nordisk cut prices for its drug Wegovy. This move is prompting generic companies to lower their expected launch prices. Novo Nordisk is also preparing to launch Ozempic in India s
Announcement as on 26 November 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 41.75
  • 12Day Average: 40.74
  • 20Day Average: 39.66
  • 50Day Average: 38.86
  • 100Day Average: 46.13
  • 150Day Average: 48.06
  • 200Day Average: 50.32

NVO Indicators & signals

Indicator MACD (12,26,9)

40.84, 40.01, 0.33
Indicator MACD is in positive zone

Indicator ADX (14)

27.47, 38.93, 22.15
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Fri May 2026 43.88 43.10 to 44.04 3.93% 1.53 times
30 Thu Apr 2026 42.22 41.65 to 42.86 4.79% 1.47 times
29 Wed Apr 2026 40.29 39.70 to 40.78 -2.14% 0.95 times
28 Tue Apr 2026 41.17 41.10 to 42.08 -0.05% 0.96 times
27 Mon Apr 2026 41.19 40.55 to 41.73 0.05% 0.97 times
24 Fri Apr 2026 41.17 38.22 to 41.23 6.88% 1.2 times
23 Thu Apr 2026 38.52 38.02 to 39.20 -1.61% 0.72 times
22 Wed Apr 2026 39.15 38.85 to 39.33 -0.68% 1.02 times
21 Tue Apr 2026 39.42 38.70 to 40.20 -2.59% 1.47 times
20 Mon Apr 2026 40.47 39.75 to 40.85 -0.12% 0.47 times
17 Fri Apr 2026 40.52 40.43 to 41.29 -1% 0.77 times
16 Thu Apr 2026 40.93 40.23 to 41.66 0.29% 0.73 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top